GMDA—(-17%/PM)—Omidubicel BLA submission delayed to 2H21 due to CMC issues: https://www.businesswire.com/news/home/20201214005260/en/Gamida-Cell-Provides-Regulatory-Update-on-Biologics-License-Application-for-Omidubicel